Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Paid in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Beginning Balance at Dec. 31, 2017 $ 38,500,984 $ 76,195 $ 33,881,863 $ 796,603 $ 3,746,323
Beginning Balance, shares at Dec. 31, 2017   7,619,469      
Adjustment from financial instruments update ASU 2016-01       $ (796,603) 796,603
Restricted stock grants issued   $ 731 (731)    
Restricted stock grants issued, Shares   73,155      
Stock-based compensation 80,771   80,771    
Net income 619,448       619,448
Dividends (1,995,327)       (1,995,327)
Ending Balance at Dec. 31, 2018 $ 37,205,876 $ 76,926 33,961,903   3,167,047
Ending Balance, shares at Dec. 31, 2018 7,692,624 7,692,624      
Restricted stock grants issued   $ 414 (414)    
Restricted stock grants issued, Shares   41,343      
Restricted stock grant forfeitures   $ (50) 50    
Restricted stock grant forfeitures, Shares   (4,961)      
Issuance of common stock under rights offering, net of expenses $ 6,280,987 $ 16,013 6,264,974    
Issuance of common stock under rights offering, net of expenses, Shares   1,601,291      
Stock-based compensation 102,989   102,989    
Net income 590,619       590,619
Dividends (2,114,555)       (2,114,555)
Ending Balance at Dec. 31, 2019 $ 42,065,916 $ 93,303 $ 40,329,502   $ 1,643,111
Ending Balance, shares at Dec. 31, 2019 9,330,297 9,330,297